National safety data of post-marketing use of omalizumab in severe persistent asthma in Turkey


Dursun A., Bavbek S., Misirligil Z., Erdener F., Buyukozturk S., Aydin O., ...More

30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.675-676 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 66
  • City: İstanbul
  • Country: Turkey
  • Page Numbers: pp.675-676